Replimune REPL
NASDAQ REPL
$15.04 -0.25 (-1.64%)
As of: Sep 4, 2026 · 3:59 PM EDT

Replimune (REPL) Change in Cash (2017 - 2026)

Replimune (REPL) posted Change in Cash of $86.1 million for Q1 2026, up 316.77% sequentially from $20.7 million in Q4 2025, and up 240.82% YoY from $25.3 million in Q1 2025.

Analysis

Replimune (REPL) Change in Cash (2017 - 2026) Analysis & Trends

Replimune has reported Change in Cash for 10 years, with the latest figure at $86.1 million in Q1 2026.

  • Quarterly Change in Cash rose 240.82% year-over-year to $86.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $97.9 million (up 167.03% YoY) and the FY2026 annual result came in at $97.9 million, up 167.03% from the prior year.
  • Change in Cash improved to $86.1 million in Q1 2026 per REPL's latest filing, from $20.7 million in the prior quarter.
  • Over five years, Change in Cash peaked at $117.7 million in Q4 2022 and troughed at -$61.1 million in Q1 2025.
  • A 5-year average of $4.5 million and a median of -$13.7 million in 2025 frame the typical range for Change in Cash.
  • The sharpest annual moves came in 2022 and 2023: Change in Cash surged 525.14% in 2022, then sank 736.95% in 2023.
  • Over 5 years, Change in Cash stood at $117.7 million in 2022, then slumped by 81.59% to $21.7 million in 2023, then jumped by 171.02% to $58.7 million in 2024, then sank by 64.85% to $20.7 million in 2025, then jumped by 316.77% to $86.1 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods registered $86.1 million, $20.7 million, and $4.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.42 Mn
10 Replimune 1.46 Bn 1.46 Bn - -23.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.67 Mn
Mar 31, 2026 86.07 Mn
Dec 31, 2025 20.65 Mn
Sep 30, 2025 4.92 Mn
Jun 30, 2025 -13.74 Mn
Mar 31, 2025 -61.12 Mn
Dec 31, 2024 58.75 Mn
Sep 30, 2024 -38.16 Mn
Jun 30, 2024 77.20 Mn
Mar 31, 2024 -23.15 Mn
Dec 31, 2023 21.68 Mn
Sep 30, 2023 -30.49 Mn
Jun 30, 2023 -40.11 Mn
Mar 31, 2023 -60.08 Mn
Dec 31, 2022 117.74 Mn
Sep 30, 2022 -23.32 Mn
Jun 30, 2022 6.30 Mn
Mar 31, 2022 -26.33 Mn
Dec 31, 2021 -27.69 Mn
Sep 30, 2021 -32.56 Mn